IBO — IMPACT BIOMEDICAL INC.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1834105 ·
Last close
$0.43
Market Cap
$46.36M
52W High
$0.68
52W Low
$0.40
ADV30
49,530
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 7,000 | — | -2,289,000 | -2,287,000 | 17,086,000 | 20,000 | 2,375,000 |
| Dec 2025 | 7,000 | -415,000 | -1,158,000 | 5,245,000 | 17,405,000 | 3,000 | 1,850,000 |
| Sep 2025 | 18,000 | 17,000 | -948,000 | -1,470,000 | 18,208,000 | 12,000 | 27,061,000 |
| Jun 2025 | 7,000 | -4,000 | -1,153,000 | -14,346,000 | 19,060,000 | 624,000 | 26,440,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,672,000
Investing CF
$1,000
Financing CF
$373,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.43
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-51,794,000
Inventory
$63,000
Receivables
$199,000
ST Investments
—
EBIT TTM
$-14,934,000
Pretax Income TTM
$-15,456,000
Interest Exp TTM
$522,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$39,000
EBITDA
$-4,119,750
Free Cash Flow
$-775,375
Enterprise Value
$50,693,128
Total Cash
$20,000
Total Debt
$1,103,000
Shares Out
107,821,231
Trailing EPS
$-0.29
Book Value
$0.11
ROE
-119.7%
ROA
-18.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,000 | -4,270,000 | -11,838,000 | 17,405,000 | 1,850,000 | — | -1,890,000 |
| Dec 2024 | 0 | -3,397,000 | -24,708,000 | 20,290,000 | 13,053,000 | — | -2,854,000 |
| Dec 2023 | 0 | -4,028,000 | -4,336,000 | 44,633,000 | 16,371,000 | — | -2,851,000 |
| Dec 2022 | 50,000 | -3,404,000 | -7,051,000 | 46,497,000 | 13,828,000 | — | -2,242,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | $46.77M | $4.83 | — |
| VICP | Vicapsys Life Sciences, Inc. | $46.94M | $1.45 | — |
| BYSI | BeyondSpring Inc. | $47.29M | $1.15 | — |
| CPHI | CHINA PHARMA HOLDINGS, INC. | $44.98M | $1.11 | — |
| FLNA | FILANA THERAPEUTICS, INC. | $48.79M | $1.01 | — |
News headlines (Yahoo Finance, 1h cache)
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
2026-04-03 17:52 · Yahoo
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
2025-08-18 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.